Open Access Open Access  Restricted Access Subscription or Fee Access

Nano Surgery and Current Era of Nanomedicine

Divyansh Gupta

Abstract


Nanotechnology is one of the developing fields whole ways across the world. As the word proposes, nanotechnology is the innovation that deals with the molecule size of 10^-9 m. Nanomedicine is the use of nanotechnology in medication. It is safeguarding also, and improving human wellbeing. Today, nanomedicine takes advantage of synthesized nanoparticles like dendrimers, fullerenes, carbon nanotubes, and many others to target specific tissues and organs that cannot be transported using a conventional drug. These nanoparticles may act as analytic and treatment for antiviral, antitumor or anticancer specialists. Be that as it may, innovation develops in the upcoming years, intricate nanodevices and even nanorobots will be created, first using biological matter and later utilizing more sturdy materials, for example, diamond to accomplish the most remarkable outcomes. In this review paper, the current developments in nanomedicine, the nano drugs in market will be discussed. Further nanotechnology also has its applications in nano surgery, using nano sized surgical equipment can benefit the doctors in numerous ways.


Keywords


Nanotechnology, nanomedicine, antitumor, anticancer, nanodevices, nanorobots, nano surgery

Full Text:

PDF

References


Allied Market Research. Allied Market Research. Published 2022. Accessed July 12, 2022. https://www.alliedmarketresearch.com/nanomedicine-market

Market. Nanomedicine Market Size, Share, Trends, Growth | 2022 to 2027. Market Data Forecast. Published 2022. Accessed July 12, 2022. https://www.marketdataforecast.com/market-reports/nanomedicine-market

Office. U.S. Food and Drug Administration. U.S. Food and Drug Administration. Published 2022. Accessed July 12, 2022. https://www.fda.gov/home

Office. Spikevax and Moderna COVID-19 Vaccine. U.S. Food and Drug Administration. Published 2022. Accessed July 12, 2022. https://www.fda.gov/emergency-preparedness-and-

response/coronavirus-disease-2019-covid-19/spikevax-and-moderna-covid-19-vaccine

Kohli, Vikram, et al. "An alternative method for delivering exogenous material into developing zebrafish embryos." Biotechnology and bioengineering 98.6 (2007): 1230–1241.

Singh, Sanjeev, and Arti Singh. "Current status of nanomedicine and nanosurgery." Anesthesia, Essays and Researches 7.2 (2013): 237.

Scott, N. R. "Nanotechnology and animal health." Revue Scientifique Et Technique-Office International Des Epizooties 24.1 (2005): 425.

Kirson, Eilon D., and Yoel Yaari. "A novel technique for micro-dissection of neuronal processes."Journal of neuroscience methods 98.2 (2000): 119–122.

Freitas, Robert A. "Current status of nanomedicine and medical nanorobotics." Journal of computational and theoretical nanoscience 2.1 (2005): 1–25.

Drexler, K. Eric. Nanosystems: molecular machinery, manufacturing, and computation. John Wiley & Sons, Inc., 1992.

Woods, Grace A., Nicholas J. Rommelfanger, and Guosong Hong. "Bioinspired materials for in vivo bioelectronic neural interfaces." Matter 3.4 (2020): 1087–1113.

Cembran, Arianna, et al. "Biomimetic materials and their utility in modeling the 3-dimensional neural environment." Iscience 23.1 (2020): 100788.

Anselmo, Aaron C., and Samir Mitragotri. "Nanoparticles in the clinic: An update."Bioengineering & translational medicine 4.3 (2019): e10143.

MARQUES, Margareth, et al. "Nanomaterials-Tiny particles and big challenges." 151–152 (2019), pp. 23–43, 10.1016/j.addr.2019.06.003

Office. FDA approves first-of-its kind targeted RNA-based therapy to treat a rare disease. U.S. Food and Drug Administration. Published 2020. Accessed July 12, 2022. https://www.fda.gov/news-events/press-announcements/fda-approves-first-its-kind-targeted-rna-

based-therapy-treat-rare-disease

Dolmans, Dennis EJGJ, Dai Fukumura, and Rakesh K. Jain. "Photodynamic therapy for cancer." Nature reviews cancer 3.5 (2003): 380–387.

Peng, Qian, et al. "Antitumor effect of 5-aminolevulinic acid-mediated photodynamic therapy can be enhanced by the use of a low dose of photofrin in human tumor xenografts." Cancer research 61.15 (2001): 5824–5832.

Dougherty, Thomas J., et al. "Photodynamic therapy." JNCI: Journal of the national cancer institute 90.12 (1998): 889–905.

Ciulla, Thomas A., et al. "Changing therapeutic paradigms for exudative age-related macular degeneration: antiangiogenic agents and photodynamic therapy." Expert opinion on investigational drugs 8.12 (1999): 2173–2182.

Richter, Anna M., et al. "Liposomal delivery of a photosensitizer, benzoporphyrin derivative monoacid ring A (BPD), to tumor tissue in a mouse tumor model." Photochemistry and photobiology 57 (1993): 1000–1006.

Maggiorella, Laurence, et al. "Nanoscale radiotherapy with hafnium oxide nanoparticles." Future oncology 8.9 (2012): 1167-1181.

Marill, Julie, et al. "Hafnium oxide nanoparticles: toward an in vitropredictive biological effect?" Radiation Oncology 9.1 (2014): 1–11.

Pottier, Agnes, Elsa Borghi, and Laurent Levy. "New use of metals as nanosized radioenhancers."Anticancer Research 34.1 (2014): 443–453.

Giner-Casares, Juan J., et al. "Inorganic nanoparticles for biomedicine: where materials scientists meet medical research." Materials Today 19.1 (2016): 19–28.

Paepke, S., et al. "SPIO (Magtrace®)-guided Sentinel Lymph Node Biopsy (SLNB) in early breast cancer–first monoinstitutional data and perspectives." Geburtshilfe und Frauenheilkunde 80.06 (2020): 95.




DOI: https://doi.org/10.37628/ijn.v8i1.893

Refbacks

  • There are currently no refbacks.